Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Exploratory Observational Study Evaluating Specific Biomarkers in Primary Invasive Breast Cancer and Their Modulation by Standard Neoadjuvant Therapy

NCT01476111 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01476111
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01476111 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Exploratory Observational Study Evaluating Specific Biomarkers in Primary Invasive Breast Cancer and Their Modulation by Standard Neoadjuvant Therapy
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Terminated
Start date
December 31, 2011
Completion date
July 31, 2014
Enrollment
117 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasms, breast